These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

286 related articles for article (PubMed ID: 26544706)

  • 1. Effectiveness of hormonal contraception in HIV-infected women using antiretroviral therapy.
    Pyra M; Heffron R; Mugo NR; Nanda K; Thomas KK; Celum C; Kourtis AP; Were E; Rees H; Bukusi E; Baeten JM;
    AIDS; 2015 Nov; 29(17):2353-9. PubMed ID: 26544706
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Concomitant contraceptive implant and efavirenz use in women living with HIV: perspectives on current evidence and policy implications for family planning and HIV treatment guidelines.
    Patel RC; Morroni C; Scarsi KK; Sripipatana T; Kiarie J; Cohen CR
    J Int AIDS Soc; 2017 May; 20(1):21396. PubMed ID: 28530033
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pregnancy rates in HIV-positive women using contraceptives and efavirenz-based or nevirapine-based antiretroviral therapy in Kenya: a retrospective cohort study.
    Patel RC; Onono M; Gandhi M; Blat C; Hagey J; Shade SB; Vittinghoff E; Bukusi EA; Newmann SJ; Cohen CR
    Lancet HIV; 2015 Nov; 2(11):e474-82. PubMed ID: 26520927
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Associations of hormonal contraceptive use with measures of HIV disease progression and antiretroviral therapy effectiveness.
    Whiteman MK; Jeng G; Samarina A; Akatova N; Martirosyan M; Kissin DM; Curtis KM; Marchbanks PA; Hillis SD; Mandel MG; Jamieson DJ
    Contraception; 2016 Jan; 93(1):17-24. PubMed ID: 26197261
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Brief Report: Hormonal Contraception Is Not Associated With Reduced ART Effectiveness Among Women Initiating ART: Evidence From Longitudinal Data.
    Patel RC; Baeten JM; Heffron R; Hong T; Davis NL; Nanda K; Coombs RW; Lingappa JR; Bukusi EA; Hurst S; Thomas KK; Kourtis AP; Mugo N;
    J Acquir Immune Defic Syndr; 2017 May; 75(1):91-96. PubMed ID: 28399558
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The influence of partnership on contraceptive use among HIV-infected women accessing antiretroviral therapy in rural Uganda.
    Nieves CI; Kaida A; Seage GR; Kabakyenga J; Muyindike W; Boum Y; Mocello AR; Martin JN; Hunt PW; Haberer JE; Bangsberg DR; Matthews LT
    Contraception; 2015 Aug; 92(2):152-9. PubMed ID: 25983013
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oral and injectable contraceptive use and HIV acquisition risk among women in four African countries: a secondary analysis of data from a microbicide trial.
    Balkus JE; Brown ER; Hillier SL; Coletti A; Ramjee G; Mgodi N; Makanani B; Reid C; Martinson F; Soto-Torres L; Abdool Karim SS; Chirenje ZM
    Contraception; 2016 Jan; 93(1):25-31. PubMed ID: 26519646
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Brief Report: Dapivirine Vaginal Ring Use Does Not Diminish the Effectiveness of Hormonal Contraception.
    Balkus JE; Palanee-Phillips T; Reddy K; Siva S; Harkoo I; Nakabiito C; Kintu K; Nair G; Chappell C; Kiweewa FM; Kabwigu S; Naidoo L; Jeenarain N; Marzinke M; Soto-Torres L; Brown ER; Baeten JM
    J Acquir Immune Defic Syndr; 2017 Oct; 76(2):e47-e51. PubMed ID: 28542081
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hormonal Contraception, Pregnancy, Breastfeeding, and Risk of HIV Disease Progression Among Zambian Women.
    Wall KM; Kilembe W; Haddad L; Vwalika B; Lakhi S; Khu NH; Brill I; Chomba E; Mulenga J; Tichacek A; Allen S
    J Acquir Immune Defic Syndr; 2016 Mar; 71(3):345-52. PubMed ID: 26379070
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Contraceptive implant use duration is not associated with breakthrough pregnancy among women living with HIV and using efavirenz: a retrospective, longitudinal analysis.
    Stalter RM; Amorim G; Mocello AR; Jakait B; Shepherd BE; Musick B; Bernard C; Bukusi EA; Wools-Kaloustian K; Cohen CR; Yiannoutsos CT; Patel RC;
    J Int AIDS Soc; 2022 Sep; 25(9):e26001. PubMed ID: 36073977
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pre-exposure prophylaxis for HIV-1 prevention does not diminish the pregnancy prevention effectiveness of hormonal contraception.
    Murnane PM; Heffron R; Ronald A; Bukusi EA; Donnell D; Mugo NR; Were E; Mujugira A; Kiarie J; Celum C; Baeten JM;
    AIDS; 2014 Jul; 28(12):1825-30. PubMed ID: 24785951
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hormonal contraceptives for contraception in overweight or obese women.
    Lopez LM; Grimes DA; Chen M; Otterness C; Westhoff C; Edelman A; Helmerhorst FM
    Cochrane Database Syst Rev; 2013 Apr; (4):CD008452. PubMed ID: 23633356
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Trends in contraceptive use according to HIV status among privately insured women in the United States.
    Haddad LB; Monsour M; Tepper NK; Whiteman MK; Kourtis AP; Jamieson DJ
    Am J Obstet Gynecol; 2017 Dec; 217(6):676.e1-676.e11. PubMed ID: 28866122
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Unintended Pregnancies Observed With Combined Use of the Levonorgestrel Contraceptive Implant and Efavirenz-based Antiretroviral Therapy: A Three-Arm Pharmacokinetic Evaluation Over 48 Weeks.
    Scarsi KK; Darin KM; Nakalema S; Back DJ; Byakika-Kibwika P; Else LJ; Dilly Penchala S; Buzibye A; Cohn SE; Merry C; Lamorde M
    Clin Infect Dis; 2016 Mar; 62(6):675-682. PubMed ID: 26646680
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hormonal contraception does not increase women's HIV acquisition risk in Zambian discordant couples, 1994-2012.
    Wall KM; Kilembe W; Vwalika B; Htee Khu N; Brill I; Chomba E; Johnson BA; Haddad L; Tichacek A; Allen S
    Contraception; 2015 Jun; 91(6):480-7. PubMed ID: 25708502
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Brief Report: HIV Shedding in the Female Genital Tract of Women on ART and Progestin Contraception: Extended Follow-up Results of a Randomized Clinical Trial.
    Kourtis AP; Wiener J; Hurst S; Nelson JAE; Cottrell ML; Corbett A; Chinula L; Msika A; Haddad LB; Tang JH
    J Acquir Immune Defic Syndr; 2019 Jun; 81(2):163-165. PubMed ID: 31095006
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nevirapine-based antiretroviral therapy does not reduce oral contraceptive effectiveness.
    Nanda K; Delany-Moretlwe S; Dubé K; Lendvay A; Kwok C; Molife L; Nakubulwa S; Edward VA; Mpairwe B; Mirembe FM
    AIDS; 2013 Oct; 27 Suppl 1():S17-25. PubMed ID: 24088680
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of concurrent use of anti-retroviral therapy and levonorgestrel sub-dermal implant for contraception on CD4 counts: a prospective cohort study in Kenya.
    Hubacher D; Liku J; Kiarie J; Rakwar J; Muiruri P; Omwenga J; Chen PL
    J Int AIDS Soc; 2013 Mar; 16(1):18448. PubMed ID: 23458102
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of Pregnancy on Response to Antiretroviral Therapy in HIV-Infected African Women.
    Kourtis AP; Wiener J; King CC; Heffron R; Mugo NR; Nanda K; Pyra M; Donnell D; Celum C; Lingappa JR; Baeten JM;
    J Acquir Immune Defic Syndr; 2017 Jan; 74(1):38-43. PubMed ID: 27787340
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association between injectable progestin-only contraceptives and HIV acquisition and HIV target cell frequency in the female genital tract in South African women: a prospective cohort study.
    Byrne EH; Anahtar MN; Cohen KE; Moodley A; Padavattan N; Ismail N; Bowman BA; Olson GS; Mabhula A; Leslie A; Ndung'u T; Walker BD; Ghebremichael MS; Dong KL; Kwon DS
    Lancet Infect Dis; 2016 Apr; 16(4):441-8. PubMed ID: 26723758
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.